Pioneering Male Contraceptive Pill Passes First Safety Test

YCT-529 represents a major advance in male contraception. Its first successful human test marks a promising start. The pill will share family planning responsibility with men, offering relief to women. It could be transformative for countries like India.
The YCT-529 pill is set to hit the market in five years.

Source: aajtak

Moving towards a male contraceptive pill has taken a big step forward. YCT-529, a groundbreaking new pill, has passed its first human safety test. This hormone-free pill halts the production of sperm in men, demonstrated in an initial trial involving 16 participants, ensuring the pill reaches the body adequately and checking for severe side effects.

The good news is no major side effects were observed. Now advancing to larger evaluations, this innovation will further explore its safety and efficacy. Let’s delve into what YCT-529 is, how it functions, and why it stands out for men.

What is the New Male Contraceptive Pill?

Until now, men had only two contraceptive options: condoms and vasectomy. Condoms must be used every time, while vasectomy is irreversible. Enter YCT-529, potentially the new, straightforward option that could change the game.

Also Read: Men's Contraceptive Injection Brings 13 Years of Relief
male birth control pill

Source: aajtak

The results of this trial were published in the Communications Medicine journal on July 22, 2025. Developed by the University of Minnesota and Columbia University, YourChoice Therapeutics is conducting the trials.

Also Read: Five Years More... World’s First Capital to Run Out of Water, Is Bangalore Next?
How Does YCT-529 Work?

Understanding how YCT-529 functions to halt sperm production:

Scientists assembled this pill by deeply analyzing the retinoic acid receptor's structure, testing numerous molecules to formulate the optimal drug.

male birth control pill

Source: aajtak

The First Human Test: What Happened?

Executed on 16 men (ages 32 to 59), the initial test aimed to detect...

Highlight:

All participants had previously undergone vasectomy, ensuring any prolonged effects of the pill did not endanger fertility.

Testing Method

Participants received either a placebo, a low dose (90mg), or a higher dose (180mg). Some took the pill on an empty stomach, others post-meal, to observe food’s impact on the pill’s effect.

Also Read: Typhoon Wifa... Deluge in the Philippine City of Quezon, Flood-Stricken Residents - See PHOTOS
Results

The pill’s absorption was excellent across doses, with 180mg showing the best outcomes, likely the dose moving forward. No significant side effects appeared—no hormonal, mood, or sexual health changes. A daily single dose might be sufficient, though subsequent trials will confirm.

Dr. Stephanie Page (University of Washington) remarked that this is a monumental step towards introducing a new male contraceptive method. A reversible method for men is urgently needed.

male birth control pill

Source: aajtak

Animal Testing: What Do the Results Indicate?

Prior testing involved mice and monkeys...

Mice:

Sperm production ceased within 4 weeks of administration. Fertility returned 4-6 weeks after stopping. 99% pregnancy prevention observed in female mating tests.

Monkeys:

Sperm count significantly reduced within 2 weeks. Fertility fully restored within 10-15 weeks post-treatment.

These outcomes cleared the path for human trials.

Also Read: After 62 Years, Indian Air Force Bids Farewell to MIG-21, Awaiting Tejas...
Why is This Pill Necessary?

The male contraceptive pill holds distinct significance...

Researcher Gunda Georg (University of Minnesota), creator of this pill, claims it offers couples more choices, granting men a more significant role in family planning.

Also Read: Chinese Engineer Steals US Missile Tech, Transfers 3600 Files on Detection, Tracking
What’s Next?

Upon completing the initial trial, now begins a series of larger tests...

28 and 90-Day Trials:

Ongoing trials require men to take YCT-529 for 28 and 90 days, studying safety and sperm count impact.

More Participants:

Future trials will involve more men, thoroughly assessing side effects.

Couples Testing:

Future trials might involve couples to examine the pill’s pregnancy prevention efficacy.

Awaiting Approval:

If successful, the pill might hit the market by 2030.

Nadja Mannowetz (YourChoice Therapeutics) explains testing prioritizes men with vasectomies or no desire for children, ensuring risk-free trials.

Challenges Ahead
Also Read: Could this Country Disappear Soon? Half of the Population Applies to Move to Australia
What Does This Mean for India?

In a country like India, where population control is a significant challenge, this pill could be revolutionary. Currently, only condoms and vasectomies serve as male contraceptives in India. If YCT-529 becomes affordable and readily available...

You might also like